INFORMACIÓN DE FÁRMACOS USADOS:
|
|
|
FÁRMACO 1:
|
|
|
|
Experimental |
|
JNJ-67856633-ZAF |
|
|
|
Not available |
|
JNJ-67856633-ZAF |
|
Cápsula* |
|
Until Disease progression, Intolerable toxicity, W |
Contenido del fármaco
|
|
No
|
|
No
|
|
No
|
|
No
|
|
No
|
|
No
|
|
No
|
|
No
|
|
No
|
|
No
|
|
No
|
|
No
|
|
No
|
|
FÁRMACO 2:
|
|
|
|
Experimental |
|
JNJ-64264681 |
|
|
|
Not Available |
|
JNJ-64264681 |
|
Cápsula* |
|
Until Disease progression, Intolerable toxicity, W |
Contenido del fármaco
|
|
No
|
|
No
|
|
No
|
|
No
|
|
No
|
|
No
|
|
No
|
|
No
|
|
No
|
|
No
|
|
No
|
|
No
|
|
No
|
|
FÁRMACO 3:
|
|
|
|
Experimental |
|
JNJ-64264681 |
|
|
|
Not Available |
|
JNJ-64264681 |
|
Cápsula* |
|
Until Disease progression, Intolerable toxicity, W |
Contenido del fármaco
|
|
No
|
|
No
|
|
No
|
|
No
|
|
No
|
|
No
|
|
No
|
|
No
|
|
No
|
|
No
|
|
No
|
|
No
|
|
No
|
|
FÁRMACO 4:
|
|
|
|
Experimental |
|
JNJ-67856633-ZAF |
|
|
|
Not available |
|
JNJ-67856633-ZAF |
|
Cápsula* |
|
Until Disease progression, Intolerable toxicity, W |
Contenido del fármaco
|
|
No
|
|
No
|
|
No
|
|
No
|
|
No
|
|
No
|
|
No
|
|
No
|
|
No
|
|
No
|
|
No
|
|
No
|
|
No
|
|
INFORMACIÓN DE PLACEBOS USADOS:
|
|
No hay placebos asignados al ensayo |